{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors", "item": "https://www.patentleaderboard.com/patent/9981970"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors

Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors

US Patent 9981970 · Granted May 29, 2018

Estimated economic value: $71,857,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic devices with dual track dynamic voltage and frequency management2025
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabo2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflamma2025
Dual-drug co-delivery system, preparation method therefor and use thereof2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
PCSK9 antagonist compounds2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
PCSK9 antagonist compounds2024
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2024